Studies have shown that fibroblast growth factor 21 (FGF21) improves hyperlipidemia and insulin resistance and increases energy expenditure in obese animals, leading to weight loss (Li et al., 2021a; Li et al., 2024). The gene discussed is FGF21; the disease is hyperlipidemia.